日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A multi-antigen-based SARS-CoV-2 vaccine provides higher immune responses and protection against SARS-CoV-2 variants.

基于多抗原的SARS-CoV-2疫苗可提供更高的免疫反应,并能有效预防SARS-CoV-2变种病毒感染

Alhashimi Marwa, Sayedahmed Ekramy E, Elkashif Ahmed, Chothe Shubhada K, Wang Wen-Chien, Murala Muralimanohara S T, Gairola Vivek, Wakamatsu Nobuko, Gontu Abhinay, Ramasamy Santhamani, LaBella Lindsey, Jakka Padmaja, Nair Meera Surendran, Nissly Ruth H, Kuchipudi Suresh V, Mittal Suresh K

A bovine adenoviral-vector-based universal influenza vaccine confers protection against influenza A and B viruses in mice and ferrets.

一种基于牛腺病毒载体的通用流感疫苗可保护小鼠和雪貂免受甲型和乙型流感病毒的感染

Wang Wen-Chien, Sayedahmed Ekramy E, Alhashimi Marwa, Elkashif Ahmed, Gairola Vivek, Murala Muralimanohara S T, Sambhara Suryaprakash, Mittal Suresh K

Adenoviral Vector-Based Vaccine Expressing Hemagglutinin Stem Region with Autophagy-Inducing Peptide Confers Cross-Protection Against Group 1 and 2 Influenza A Viruses

基于腺病毒载体的疫苗表达血凝素茎区和自噬诱导肽,可对1组和2组甲型流感病毒提供交叉保护

Wang, Wen-Chien; Sayedahmed, Ekramy E; Alhashimi, Marwa; Elkashif, Ahmed; Gairola, Vivek; Murala, Muralimanohara S T; Sambhara, Suryaprakash; Mittal, Suresh K

Bovine Adenoviral Vector-Based Platform for Vaccine Development

基于牛腺病毒载体的疫苗研发平台

Sayedahmed, Ekramy E; Gairola, Vivek; Murala, Muralimanohara S T; Mittal, Suresh K

Next-Generation Adenoviral Vector-Based Vaccines for Severe Acute Respiratory Syndrome Coronavirus-2

用于严重急性呼吸综合征冠状病毒2的下一代腺病毒载体疫苗

Murala, Muralimanohara S T; Gairola, Vivek; Sayedahmed, Ekramy E; Mittal, Suresh K